1.         Yu Q, Cheng D, Xu L, Li Y, Zheng X, Liu Y, Li Y, Liu H, Bai L, Wang R, Fan J, Liu E*, Zhao S*.Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits. Acta Pharmacol Sin. 2019. In press. (* 通讯作者)

2.         Zhao SH, Li YK, Guo J, Lu HS, Zheng XY, Chen XF, et al. Myeloid Cell specific Deficiency of Hif-la or Vegf-a Attenuates Experimental Atherosclerosis. Arterioscler Thromb Vasc Biol. 2019,39(Supp1): Abstract: A521.

3.         Wang R, Liu R, Li L, Liu B, Bai L, Wang W, Zhao S, Liu E. Fasting is not required for measuring plasma lipid levels in rabbits. Lab Anim. 2019 Jun 19:23677219855102. doi: 10.1177/0023677219855102. [Epub ahead of print]

4.         Bai L#, Liu B#, Ji C#, Zhao S#, Liu S, Wang R, Wang W, Yao P, Li X, Fu X, Yu H, Liu M, Han F, Guan N, Liu H, Liu D, Tao Y, Wang Z, Yan S, Florant G, Butcher MT, Zhang J, Zheng H, Fan J, Enqi Liu. Hypoxic and Cold Adaptation Insights from the Himalayan Marmot Genome. iScience. 2019 Jan 25;11:519-530. (# 共同第一作者)


5.         Gao S, Xu L, Zhang Y, Yu Q, Li J, Guan H, Wang X, Cheng D, Liu Y, Bai L, Wang R, Fan J, Zhao S*, Liu E*. Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell via Akt/mTOR Signaling. Cell Physiol Biochem. 2018;50(5):1740-1753. (* 通讯作者)

6.         成大欣; 徐丽然; 于清清; 高守翠; 王晓靖; 刘懿; 刘恩岐; 赵四海(*).一种简单的gRNA体外筛选方法. 实验动物与比较医学, 2018, (02): 126-129. (* 通讯作者)

7.         Liu B, Zhang Y, Wang R, An Y, Gao W, Bai L, Li Y, Zhao S, Fan J, Liu E. Western diet feeding influences gut microbiota profiles in apoE knockout mice. Lipids Health Dis. 2018 Jul 18;17(1):159.

8.         Guan H, Zhang Y, Gao S, Bai L, Zhao S, Cheng XW, Fan J, Liu E. Differential Patterns of Secreted Frizzled-Related Protein 4 (SFRP4) in Adipocyte Differentiation: Adipose Depot Specificity. Cell Physiol Biochem. 2018;46(5):2149-2164.

9.         Wang W, Chen Y, Bai L, Zhao S, Wang R, Liu B, Zhang Y, Fan J, Liu E. Transcriptomic analysis of the liver of cholesterol-fed rabbits reveals altered hepatic lipid metabolism and inflammatory response. Sci Rep. 2018 Apr 24;8(1):6437.

10.     Wang R, Yang L, Zhang Y, Li J, Xu L, Xiao Y, Zhang Q, Bai L, Zhao S, Liu E, Zhang YJ. Porcine reproductive and respiratory syndrome virus induces HMGB1 secretion via activating PKC-delta to trigger inflammatory response. Virology. 2018;518:172-183.

11.     刘懿,赵四海.结直肠癌患者血清TK1sICAM-1miR-210CEA的检测及分析.国际检验医学杂志,2018,39(09):1048-1051+1055.

12.     成大欣,张勤,芦红茹,刘合芳,赵四海.2012-2016年住院新生儿死亡率及死因分析.西安交通大学学报(医学版),2018,39(01):106-110.


13.     Gao S, Wang X, Cheng D, Li J, Li L, Ran L, Zhao S, Fan J, Liu E. Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits. Mediators Inflamm. 2017;2017:3824276.

14.     成大欣,刘懿,徐丽然,于清清,赵四海.干扰素治疗儿童乙型病毒性肝炎有效性和安全性的Meta分析.中国循证医学杂志,2017,17(11):1298-1304.

15.     成大欣; 徐丽然; 于清清; 高守翠; 王晓靖; 刘懿; 刘恩岐; 赵四海. 制备和检测胚胎显微操作用针的实用方法体系. 西安交通大学学报(医学版), 2017.10, (06): 917-920.

16.     Bai L, Li Z, Li Q, Guan H, Zhao S, Liu R, Wang R, Zhang J, Jia Y, Fan J, Wang N, Reddy JK, Shyy JY, Liu E. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization. Arterioscler Thromb Vasc Biol. 2017;37(8):1470-1481.


17.     Yu H, Guo S, Wang L, Dong Y, Tian G, Mu S, Zhang H, Li D*, Zhao S*. Laparoscopic Splenectomy and Esophagogastric Devascularization for Liver Cirrhosis and Portal Hypertension Is a Safe, Effective, and Minimally Invasive Operation. J Laparoendosc Adv Surg Tech A. 2016;26(7):524-30. (* 通讯作者)

18.     Wang R, Zhang Y, Xu L, Lin Y, Yang X, Bai L, Chen Y, Zhao S, Fan J, Cheng X, Liu E. Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice. Sci Rep. 2016;6:36790.

19.     Lin Y, Chen Y, Zhu N, Zhao S, Fan J, Liu E. Hydrogen sulfide inhibits development of atherosclerosis through up-regulating protein S-nitrosylation. Biomed Pharmacother. 2016;83:466-476.

20.     An Y, Gao S, Cheng D, Wang X, Bai L, Liu E, Chu Y, Zhao S*. Peginterferon and Chinese herbs exert a combinatorial effect in HBeAg-positive chronic hepatitis B. J Infect Dev Ctries. 2016;10(4):369-76. (* 通讯作者)

21.     Du H, Liu E, Xu C, Zhao S, Xiang H, Li Z. Prognostic value of funisitis and/or chorionic vasculitis compared to histologic chorioamnionitis in full-term infants. J Matern Fetal Neonatal Med. 2017;30(2):169-173.

22.     Bai L, Li Q, Li L, Lin Y, Zhao S, Wang W, Wang R, Li Y, Yuan J, Wang C, Wang Z, Fan J, Liu E. Plasma High-Mannose and Complex/Hybrid N-Glycans Are Associated with Hypercholesterolemia in Humans and Rabbits. PLoS One. 2016;11(3):e0146982.

23.     Guan H, Lin Y, Bai L, An Y, Shang J, Wang Z, Zhao S, Fan J, Liu E. Dietary Cocoa Powder Improves Hyperlipidemia and Reduces Atherosclerosis in apoE Deficient Mice through the Inhibition of Hepatic Endoplasmic Reticulum Stress. Mediators Inflamm. 2016:1937572.

24.     Wu M, Ai W, Chen L, Zhao S, Liu E. Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice. Int J Mol Med. 2016;37(3):565-74.


25.     Zhao S, Li Y, Gao S, Wang X, Sun L, Cheng D, Bai L, Guan H, Wang R, Fan J, Liu E. Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits. Biomed Res Int. 2015:843959.

26.     余琦,张光伟,陈玉龙,孙文涛,程功,姚丹丹,赵四海*,刘恩岐.以科研助力《实验动物学》教学培养创新型人才. 西北医学教育.2015;23(4): 657-658. (* 通讯作者)

27.     Lin Y, Bai L, Chen Y, Zhu N, Bai Y, Li Q, Zhao S, Fan J, Liu E. Practical assessment of the quantification of atherosclerotic lesions in apoE/ mice. Mol Med Rep. 2015;12(4):5298-306.

28.     Wang Y, Bai L, Lin Y, Chen Y, Guan H, Zhu N, Li Y, Gao S, Sun L, Zhao S, Fan J, Liu E. Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits. Lipids Health Dis. 2015;14:82.

29.     Cheng D, Wang Y, Gao S, Wang X, Sun W, Bai L, Cheng G, Chu Y, Zhao S*, Liu E*. Atorvastatin delays the glucose clearance rate in hypercholesterolemic rabbits. Biomed Pharmacother. 2015;72:24-9. (* 通讯作者)

30.     Wang C, Li Y, Gao S, Cheng D, Zhao S, Liu E. Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients. PLoS One. 2015;10(6):e0129969.

31.     Li Y, Gao S, An Y, Liu E, Zhao S*. High dose atorvastatin therapy yields a better carotid atherosclerosis improvement in Chinese patients. Int J Cardiol. 2015;185:131-2. (* 通讯作者)

32.     高守翠,成大欣,赵四海,陈玉龙,王晓靖,白亮,范江霖,刘恩岐.胆固醇酯转移蛋白转基因家兔制作及生物学特性分析[J].中国实验动物学报,2015,23(04):331-335.

33.     白亮,王蓉,罗肖,赵四海,刘恩岐.激活PPARα缓解PPARγ诱导的小鼠脂肪肝[J].中国实验动物学报,2015,23(04):342-346.

34.     白亮,李倩薇,赵四海,贾玉枝,REDDY Janardan K,刘恩岐.PPARγ及其辅激活子MED1重组腺病毒的制备与生物学功能分析[J].西安交通大学学报(医学版),2015,36(03):294-298.


35.     李倩薇,刘芮菡,赵四海,贾玉枝,白亮,Janardan K.Reddy,徐小平,刘恩岐.高脂饮食诱导肝脏MED1特异性敲除小鼠呈高胆固醇血症[J].中国生物化学与分子生物学报,2014,30(11):1113-1118.

36.     Wang Y, Bai L, Lin Y, Guan H, Zhu N, Chen Y, Li Y, Gao S, Zhao S, Fan J, Liu E. Demonstration of an add-on effect of probucol and cilostazol on the statin-induced anti-atherogenic effects. Histol Histopathol. 2014;29(12):1593-600.

37.     Li Y, Zhao S, Wang Y, Chen Y, Lin Y, Zhu N, Zheng H, Wu M, Cheng D, Lin Y, Bai L, Fan J, and Liu E. Urotensin II promotes atherosclerosis in cholesterol-fed rabbits. PLoS One. 2014 Apr 18;9(4):e95089.(* 通讯作者)

38.     Chen Y, Zhao S, Huang B, Wang Y, Li Y, Waqar AB, Liu R, Bai L, Fan J, Liu E. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits. Thromb Res. 2013;132(5):565-71.

39.     Cheng D, Liu E, Li Y, Liu R, Bai L, Chen Y, Wang Y, Chu Y, Wu M, Cheng G, Zhao S*. Peginterferon Plus Chinese Herbal Therapy is Associated with a Higher Virological Response than only Peginterferon Therapy in Chronic Hepatitis C. Eur J Clin Microbiol Infect Dis. 2014,33(3):433-438. (* 通讯作者)

40.     Wang Y, Zhao S, Bai L, Fan J, Liu E. Expression systems and species used for transgenic animal bioreactors. BioMed Research International. 2013;2013:580463

41.     赵四海,朱虹,陈宏列,白亮,成大欣,范江霖,刘恩岐.尾加压素转基因家兔制作及其影响因素分析. 西安交通大学学报(医学版). 2013,34(4):537-540.

42.     赵四海, 刘恩岐*, 白亮, 金昕, 朱虹, 陈宏列, 闫西才, 李喜琴. 在动物实验中遵循6R原则以提高医学研究生科研水平. 西北医学教育. 2013;20(1): 71-73.

43.     Zhang R, Yan JD, Valenzuela RK, Lu SM, Du XY, Zhong B, Ren J, Zhao SH, Gao CG, Wang L, Guo TW, Ma J. Further evidence for the association of genetic variants of ZNF804A with schizophrenia and a meta-analysis for genome-wide significance variant rs1344706. Schizophr Res. 2012;141(1):40-7.

44.     赵四海, 刘恩岐*, 白亮, 金昕, 朱虹, 陈宏列, 闫西才, 张峰. 4R原则贯穿实验动物学教学全程以提高医学生科研素质. 西北医学教育. 2012;20(4):755-756. (* 通讯作者)

45.     Yulong Chen, Zhongdong Wang, Guangwei Zhang, Wei Fan, Yuanqing Tao, Xue He, Sihai Zhao, Bingqiao Huang, Jianglin Fan, Kitajima Shuji, Enqi Liu. Genetic characterization of four wild species of Chinese marmots using microsatellite markers. Biologia. 2012. 67(5):1013-1017.

46.     Zhao S, Liu Enqi, Cheng D, Li Y, Wang Y, Chen Y, Sun W,  Yan X, Dang S. Comparison of entecavir and adefovir for the treatment of chronic hepatitis B. Brazilian Journal of Infectious Diseases. 2012;16(4):366-72. (* 通讯作者)

47.     Zhang G, Wei K, Liu E, Wang Yi, Li Y, Yu Q, Chen Y, Huang B, Lu S, Yan X, Zhao S*. The effects of rosiglitazone on fatty liver of high fat and cholesterol-fed rabbits. J Anim Vet Adv. 2012;(11)14:2564-2569 .(* 通讯作者)

48.     Wang Y, Cheng F, Chen Y, Li Y, Zhao S, Yu Q, Fan J, Liu E*. High-Dose Rosiglitazone is Pro-atherogenic in Cholesterol-fed Rabbits. Atherosclerosis. 2012,222(1):292-4.

49.     Li Y, Wang Z, Tao Y, Fan W, Li M, Huang B, Zhao S, Fan J, Liu E*.  Characteristics of Himalayan Marmots and their response to an atherogenic diet. Exp Anim. 2012;61(4):461-6.

50.     Yu Q, Li Y, Wang Y, Yu Y, Zhao S, Chen Y, Waqar AB, Fan J, Liu E*. Expression of TRPV1 in rabbits and consuming hot pepper affects its body weight. Mol Biol Rep. 2012 Jul;39(7):7583-9.

51.     Yu Q, Li Y, Waqar AB, Wang Y, Huang B, Chen Y, Zhao S, Yang P, Fan J, Liu E*. Temporal and quantitative analysis of atherosclerotic lesions in diet-induced hypercholesterolemic rabbits. J Biomed Biotechnol. 2012:506159.

52.     Yu Q, Liu E, Zhao S*, Li Y, Wang Y, Wei K, Huang B, Chen Y, Fan J, Yang P. Association of TaqIB Polymorphism of Cholesteryl Ester Transfer Protein and Coronary Artery Disease in Chinese Population. J Zhejiang Univ-Sci B (Biomed & Biotechnol) 2012 13(5):342-347.

53.     Yu Q, Li Y, Wang Y, Zhao S, Yang P, Chen Y, Fan J, and Liu E. C-reactive protein levels are associated with the progression of atherosclerotic lesions in rabbits. Histology and Histopathology. Histol Histopathol. 2012,27(4): 529-535.

54.     Yu Q, Lin Y, Yang P, Wang Y, Zhao S, Yang P, Fan J, Liu E. C-reactive protein is associated with the progression of acute embolic stroke in rabbit model. J Thromb Thrombolysis. 2012,33(4):301-7.

55.     Dang S, Wang W, Wang X, Li Y, Li M, Jia X, Wang Y, Liu E and Zhao S. Telaprevir for Chronic Hepatitis C with Genotype 1: A Meta-Analysis. Hepato-Gastroenterology. 2012.59(114):461-8.

56.     Yu H, Li D, Zhang H, Xue H, Pan C, Zhao S. Effects of ANGPTL3 antisense oligodeoxynucleotides transfection on the cell growths and invasion of human hepatocellular carcinoma cells. Hepato-Gastroenterology. 2011.58(110-111):1742-6.

57.     Zhao S*, Liu E, Wei K, Lu S, Chu Y, Li Y, Wang Y, Huang B, Chen Y, Yang P. Interferon plus Chinese herbs are associated with higher sustained virological response than interferon alone in chronic Hepatitis C: a meta-analysis of randomised trials. Antiviral Res. 2011,89(2):156-164. (* 通讯作者)  

58.     Zhao S*, Liu E, Wei K, Wang Y, Li Y, Huang B, Chen Y, Yang P. Treatment with peginterferon versus interferon in Chinese patients with chronic hepatitis C. Eur J Clin Microbiol Infect Dis. 2011,30(1):51-57. (* 通讯作者)  

59.     Yu H, Zhang H*, Li D, Zhang X, Xue H, Zhao S*. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Journal of Asian Natural Products Research. 2011. 3(13): 242–250. (* 通讯作者)      

60.     Sun W, Lei C, Zhao S, Wang L, Bi C, Wang R, Zhou X, Liu E and Chen M. Histomorphological and Ultrastructural Changes of Retinopathy in Diabetic Rabbit Model. J Anim Vet Adv. 2011,10(2):133-137.     

61.     Li Y, Wang Y, Yu Q, Wei K, Li M, Zhao S, Kurabayasgi Y, Fan J and Liu E. Compound Danshen dripping pills for stable angina: Meta-analysis of randomized controlled trials. Journal of Medicinal Plants Research. 2011,5(11):2245–2251.

62.     寻萌, 赵四海, 曹春霞, 薛欣, 邵明明, 李薇, 徐琨, 楚雍烈. 细胞角蛋白8真核表达载体的构建、表达及生物信息学分析. 细胞与分子免疫学杂志. 2011,27(2):123-127.

63.     Zhao S, Wei K, Yu Q, li Y, cheng F, Wang Y, Yang P, Fan J, liu E. General topic: applications of transgenic rabbits in biomedical research - based on literature search. World Rabbit Science. 2010,18(3):159-167.      

64.     Zhao S*, Liu E, Chen P, Cheng D, Lu S, Yu Q, Wang Y, Wei K, Yang P. A Comparison of Peginterferon α-2a and Peginterferon α-2b for Patients With Treatment-Naive Chronic Hepatitis C: A Meta-Analysis of Randomized Trials. Clinical therapeutics,2010, 32 (9):1565-1577. (* 通讯作者)    

65.     Yu H, Liu E, Lu S, Zhao S*. Treatment with peginterferon versus interferon in Chinese patients with hepatitis B. Biomedicine & Pharmacotherapy. 2010,64 (10) 559–564. (* 通讯作者)      

66.     Yu H, Zhang H*, Zhang X, Li D, Xue H, Pan C, Zhao S*. Resveratrol Inhibits VEGF Expression of Human Hepatocellular Carcinoma Cells through a NF-kappa B-mediated Mechanism. Hepato-Gastroenterology. 2010; 57:1241-1246. (* 通讯作者)     

67.     Yu H, Li D, Zhang H, Xue H, Pan C, Zhao S, Wang L. Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells. J Anim Vet Adv. 2010,9(24):3117-3124.      

68.     赵四海*, 刘恩岐, 杨鹏辉, 余琦, 魏科娜, 王艳丽, 李亚峰, 程芳, 黄炳俏.转变实验动物学的教学模式以培养生物医学研究生创新性思维能力.西北医学教育,2010,18(1):62-64. (* 通讯作者)

69.     赵四海*, 楚雍烈, 刘恩岐. 角蛋白8在四氯化碳诱导的小鼠肝损伤中的表达. 浙江大学学报( 医学版). 2010,39(1):37-42. . (* 通讯作者)

70.     薛欣, 邱奕, 楚雍烈, 赵四海, 邵明明, 曹春霞. 结核分枝杆菌异烟肼耐药基因kat G的检测. 中国病原生物学杂志. 2010,5(7):496-498.

71.     孙文涛, 雷春灵, 赵四海, 毕春潮, 张璐. 改良四氧嘧啶制作兔糖尿病模型的实验研究(英文) .国际眼科杂志. 2010,10(10):1848-1852.

72.     Li Y, Kurabayashi Y, Zhao S, Yu Q, Cheng F, Wang Y, Wei K, Liu E. Meta analysis on acupuncture treatment of aphasia. Zhen Ci Yan Jiu. 2010,35(6):468-473.

73.     Zhao S, Chu Y, Cheng D, Waqar A, Yu Q, Yang P, Xue X, Yang H. Liu E.   Treatment with peginterferon plus ribavirin versus interferon plus ribavirin for 48 weeks in Chinese patients with chronic hepatitis C. Int J Clin Pract.2009,63(9):1334-1339.    

74.     Chen P, Zhao S, Chu Y, Xu K, Zhua L, Wu Y, Song J, Cao C, Xue X and Niu Y. Anticancer activity of PDSS2, prenyl diphosphate synthase, subunit 2, in gastric cancer tissue and the SGC7901 cell line. Anticancer Drugs. 2009,20(2):141-148.  0

75.     Yu Q, Han W, Wang Y, Wei K, Zhao S, Yang P, Liu E. How effective use Hirsch index to assess a journal? A study of evaluation the Hirsch index of Chinese Medical Journal. J Anim Vet Adv. 2009,8(12):2485-2488.   

76.     赵四海, 刘恩岐, 成大欣, 薛欣, 楚雍烈. H IV 患者合并感染基因1 4 型丙型肝炎病毒治疗效果的Meta 分析. 2009,38(3):315-319.

77.     Zhao S, Xun M, Chu Y, Zhu T, Wang Y, Yan L, Xue X, Xu K, Song J, Shao M. Proteome analysis identifies the role of heat stress in production of progeny HCV in Huh7 cells harboring intact HCV. Intervirology. 2008,51(3):196-202.            

78.     Zhao S, Xun M, Chu Y, Zhu T, Xue X, Xu K, Song J, Shao M. Comparative Proteomics Analysis of Huh7 Cells Harboring Intact HCV. Chemical Journal of Chinese Universities (Chinese Edition). 2008,29(11)2174-2177.     

79.     Zhao S, Cheng D, Liu E, Yu H, Yang H, Xue X, Chu Y. Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients. European Journal of Clinical Microbiology & Infectious Diseases. 2008, 27 (12):1183–1192.  

80.     Zhao S, Zhang C, Lin Y, Yang P, Yu Q, Yang P, Chu Y, Fan J, Liu E. The effects of rosiglitazone on aortic atherosclerosis of cholesterol-fed rabbits. Thrombosis Research. 2008,123(2):281-287.       

81.     Zhao S, Liu E, Yu H, Yang H, Xun M, Xue X, Song J, Xu K, Chu Y. Comparison of peginterferon and interferon in treating Chinese patients with chronic hepatitis C. Hepato-gastroenterology. 2008;55(84):1047-1054.     

82.     Zhao S, Chu Y, Zhang C, Lin Y, Xu K, Yang P, Fan J, Liu E. Diet-induced central obesity and insulin resistance in rabbits. J Anim Physiol Anim Nutr (Berl). 2008;92(1):105-111.     

83.     赵四海, 寻萌, 楚雍烈, 朱彤, 王毅华, 闫丽鹏. 丙型肝炎病毒全基因组培养细胞中转录调节基因的差异表达. 浙江大学学报(医学版). 2008;37(2):164-169.

84.     Yu H, Pan C, Zhao S, Wang Z, Zhang H, Wu W. Resveratrol inhibits tumor necrosis factor-a-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother, 2008,62(6):366- 372.  

85.     余海波,潘承恩,吴武军,赵四海. 白藜芦醇对肝癌细胞基质金属蛋白酶-9表达的影响. 中西医结合学报. 2008,6(3):270-273.

86.     寻萌,赵四海,楚雍烈,曹春霞,安润,宋娟,徐琨,邵明明. GRP78在全长丙肝病毒RNA转染细胞中表达的研究. 中国病原生物学杂志. 2008, 3(5):326-329.

87.     Zhao S, Liu E, Chu Y, Zheng H, Kitajima S, Morimoto M. Numbers of  publications related to laboratory animals. Scandinavian Journal of Laboratory Animal Science. 2007; 34(2):81-86.      

88.     赵四海, 楚雍烈, 寻萌, 薛欣. 丙型肝炎病毒研究模型的现状与未来. 浙江大学学报(医学版).2007;36(6):614-619.

89.     赵四海, 楚雍烈, 林燕, 张春芳, 徐琨, 刘恩岐. 小鼠胚胎显微操作针的制备方法. 南方医科大学学报. 2007;27(9):1389-1390.

90.     赵四海,郑华东,楚雍烈,林燕,张春芳,陈正兰,朱虹,杨鹏辉,刘恩岐. 两种小鼠胚胎移植方法的比较. 第四军医大学学报. 2007;28(6):493-495.

91.     赵四海,楚雍烈,郑华东,杨鹏辉,陈正兰,朱虹,范江霖,刘恩岐. 过氧化物酶增殖体激活受体γ2转基因小鼠的制作及其影响因素分析. 西安交通大学学报(医学版). 2007; 28(2):134-137.

92.     余琦, 杨佩刚, 张春芳, 林燕, 陈正兰, 赵四海, 刘恩岐. 3R原则在医学实验动物学教学中的应用.西北医学教育. 2007;15(6):1128-1130.

93.     赵四海,郑华东,刘恩岐. 生物医学研究中实验动物的应用状况与分析.中国比较医学杂志. 2006;16(4):245-8

94.     刘恩岐,郑华东,赵四海,杨鹏辉. 转基因家兔的制作. 动物学杂志. 200641(3):64-71.

95.     Liu E, Zhao S, Chen Z, Ynag P. Detecting low density lipoprotein receptor mutant gene of rabbit by PCR. Acad J XJTU. 2006;18(2):199-200.

版权所有:西安交通大学 站点设计:网络信息中心 陕ICP备05001571号 联系电话:82668579 82668902 QQ群号:496666580
欢迎您访问我们的网站,您是第 位访客
推荐分辨率1024*768以上 推荐浏览器IE7 Firefox 以上